Ascendis could be poised for ‘strategic pivot’ to go private
30 September 2021 - 20:27
Ascendis Health, whose restructuring costs almost rivalled its R303m market value in its year to end-June, looks set to get a nod from shareholders on Monday on a deal from lenders that will probably result in it going private, and possibly ceasing to exist.
Shareholders must decide on a restructuring plan that will result in the group giving up its most profitable assets, leaving it with three businesses in SA: its local consumer brands business, which includes brands such as Solal; its pharmaceutical business; and parts of its medical device business...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.